|
|
Get email updates |
2008 Scientific ArticlesAsatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine 2008. Benson PJ, Jackson LA, Rees TG, Dunn JB. Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine. Human Vaccine 2008;4(3):234–237. Broder KR, Cohn AC, Schwartz B, Klein JD, Fisher MM, Fishbein DB, Mijalski C, Burstein GR, Vernon-Smiley ME, McCauley MM, Wibbelsman CJ; Working Group on Adolescent Prevention Priorities. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics 2008;121 Suppl 1:S25–34. Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, Berger T, Flanders WD, Shope R. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003–2004. Clinical Infectious Diseases 2008;46 Suppl 3:S271–293. Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Event Reporting System, 1995–2005.* Journal of Infectious Diseases 2008;197(S2):S170–S177. Clayton HA, Cortese MM, Payne DC, Bartlett DL, Zimmerman LA, Williams WG, Wang M, Stockman LJ, Parashar U, Baggs J. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination scheduleUnited States, February 2006May 2007. MMWR 2008;57(15):398401. Fishbein DB, Broder KR, Markowitz L, Messonnier N. New, and some not-so-new, vaccines for adolescents and diseases they prevent. Pediatrics 2008;121 Suppl 1:S5–14. France EK, Glanz JM, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly J, Jackson L, Nordin J, Belongia E, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008;121(3):e687–e692. Glanz JM, France EK, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008;121(3):e506–e512. Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar U; Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007 Pediatrics 2008; Volume 121:206-1212 Iskander J, Broder K. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience. Expert Review of Vaccines 2008;7(1):75–82. Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ; Vaccine Safety Datalink. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008;121(3):463–469. Leung J, Rue A, Lopez A, Ortega-Sanchez IR, Harpaz R, Guris D, Seward JF. Varicella outbreak reporting, response, management, and national surveillance.* Journal of Infectious Diseases 2008;197(S2):S108–S113. McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine 2008 May 5. McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008;26(3):427–429. Morgan J, Roper MH, Sperling L, Schieber RA, Heffelfinger JD, Casey CG, Miller JW, Santibanez S, Herwaldt B, Hightower P, Moro PL, Hibbs BF, Levine NH, Chapman LE, Iskander J, Lane JM, Wharton M, Mootrey GT, Swerdlow DL. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January–October 2003. Clinical Infectious Diseases 2008;46 Suppl 3:S242–250. Nachamkin, I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, Corcoran AT, Iskander JK, Schonberger LB, Chen RT. Anti-Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine-Associated Guillain-Barre Syndrome. Journal of Infectious Diseases 2008;198(2):226-233 Sutherland A, Izurieta H, Ball R, Braun MM, Miller ER, Broder KR, Slade BA, Iskander JK, Kroger AT, Markowitz LE, Huang WT. Syncope after vaccination—United States, January 2005–July 2007. MMWR 2008;57(17):457–460. Swerdlow DL, Roper MH, Morgan J, Schieber RA, Sperling LS, Sniadack MM, Neff L, Miller JW, Curtis CR, Marin ME, Iskander J, Moro P, Hightower P, Levine NH, McCauley M, Heffelfinger J, Damon I, Török TJ, Wharton M, Mast EE, Mootrey GT; Smallpox Vaccine Cardiac Adverse Events Working Group. Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003. Clinical Infectious Diseases 2008;46 Suppl 3:S234–241. Thomas TN, Reef S, Neff L, Sniadack MM, Mootrey GT. A review of the smallpox vaccine adverse events active surveillance system. Clinical Infectious Diseases 2008;46 Suppl 3:S212–220. Wood Robert A, Berger M, Dreskin SC, Setse R, Engler RJM, Dekker CL, Halsey NA, Working Group of the Clinical Immunization Safety Assessment (CISA) Network. An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines. Pediatrics 2008;122(3):e771-e777. *Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.
Page last reviewed: September 25, 2008
Page last updated: September 25, 2008 Content source: Immunization Safety Office, Office of the Chief Science Officer |
|
||||||||||||
|